Find plants prequalified by WHO for access-market supply. UNICEF, Global Fund, and GAVI institutional procurement pool, by molecule and region.
Eighty-eight active WHO prequalifications sit on the register today, concentrated in Guilin Pharmaceutical (34 active PQs, China), Laurus Labs (18 active PQs, India), and Antibiotice SA (7 active PQs, Romania). The cohort is the institutional procurement pool: plants that have passed the WHO assessment and can supply UNICEF, GAVI, the Global Fund, and major access-market tenders.
| # | Plant | Region | Active PQs | Other regulators | Inspection |
|---|---|---|---|---|---|
| 1 | Guilin Pharmaceutical | CN · Guilin | 34 PQs | EDQM + FDA overlap | NAI |
| 2 | Laurus Labs | IN · Anakapalli | 18 PQs | FDA + EDQM overlap | NAI |
| 3 | Antibiotice SA | RO · Iași | 7 PQs | EDQM overlap | NAI |
| 4 | Qinhuangdao Zizhu | CN · Qinhuangdao | 5 PQs | EDQM overlap | NAI |
| 5 | Shijiazhuang Lonzeal | CN · Shijiazhuang | 3 PQs | EDQM overlap | VAI |
| 6 | Micro Labs | IN · Bengaluru | 3 PQs | FDA + EDQM overlap | NAI |
| 7 | Jiangsu Weiqida | CN · Jiangsu | 2 PQs | EDQM overlap | VAI |
| 8 | Sanofi-Aventis Deutschland | DE · Frankfurt | 2 PQs | FDA + EMA overlap | NAI |
All WHO-PQ plants, region-specific, or molecule-specific. The AI agent pulls the cohort matching the filter.
Active prequalification count, parallel regulator overlap (FDA, EDQM), and inspection class join at the schema layer.
Citation-anchored brief with the qualifying plants, PQ count, regulator chips, and a molecule-coverage chip.
UNICEF, Global Fund, GAVI, and major LMIC tenders require WHO-PQ at the plant level. The cohort is pre-filtered to plants eligible to compete.
WHO-PQ plants with parallel FDA or EDQM coverage signal the highest quality tier. Trans-jurisdictional supply candidates surface as the deepest cells.
A plant with 18 active PQs has scaled its institutional supply across many molecules. A plant with one PQ may be qualified but commercially thin. The chip surfaces both.
WHO publishes register updates on a rolling cycle. PharmaDB normalises to monthly refresh; the catalog row carries an as-of timestamp.
A real chat thread in PharmaDB. Type a question, the AI agent runs the tools, the answer lands as a saveable note.
pharmagraph_query WHO-PQ register · counts by cohort and overlap category, live snapshot.
WHO-PQ accreditation is the gate for access-market institutional procurement. PharmaDB joins the live WHO register to the canonical plant catalog and surfaces the qualifying cohort with parallel regulator overlap and inspection class. The view rests on plant_accreditations (regulator=‘who_pq’). Refresh cadence is monthly.
A WHO programme that assesses pharmaceutical products and the plants making them for quality, safety, and efficacy, primarily for access-market institutional procurement. UNICEF, the Global Fund, GAVI, and major LMIC tenders typically require WHO-PQ at the plant and product level.
WHO-PQ is a UN-led assessment focused on access-market supply (LMICs, institutional buyers). FDA approval is a US regulatory action focused on the US commercial market. Many plants hold both; the WHO-PQ assessment leverages FDA inspection findings but applies WHO criteria.
Guilin has scaled its antimalarial and tuberculosis API capacity through the 2010s with WHO-PQ at the centre of its commercial model. The 34 active PQs reflect a deep institutional procurement focus, not casual coverage.
Yes. The view covers both FDF (finished dosage) and API prequalifications. The chip labels which type each PQ is; many plants hold a mix.
WHO-PQ at the plant is necessary but not sufficient for institutional procurement; the product-level prequalification matters and so does the institutional buyer's own qualification audit. The companion analysis 'Institutional procurement BD' surfaces tender flow and award patterns.
Monthly. The WHO prequalification register publishes on a rolling cycle. PharmaDB normalises to monthly refresh; the catalog row carries an as-of timestamp on every result page.
Bring the molecule, the lane, or the supplier you're sourcing this week. The AI agent runs it on PharmaDB in 30 minutes. You keep the brief.